Noble Energy Inc (NBL) 34.25 $NBL SmarTrend Watching for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Noble Energy Inc (NBL) 34.25 $NBL

SmarTrend Watching for Potential Rebound in Shares of Noble Energy After 2.75% Loss
Comtex SmarTrend(R) - Wed Aug 31, 2:58PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $34.64 to a high of $35.57. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $35.04 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NBL: 34.25 (+0.40)

Look for Shares of Noble Energy to Potentially Rebound after Yesterday's 2.75% Sell Off
Comtex SmarTrend(R) - Wed Aug 31, 2:57PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $34.64 to a high of $35.57. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $35.04 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NBL: 34.25 (+0.40)

Noble Energy (NBL) Breaks Through Support at $35.38
Comtex SmarTrend(R) - Wed Aug 31, 8:42AM CDT
Shares of Noble Energy (NYSE:NBL) opened today below their pivot of $35.80 and have already reached the first level of support at $35.38. Analysts will be watching for a cross of the next downside pivot targets of $35.14 and $34.48.
NBL: 34.25 (+0.40)

CONE Midstream (CNNX) Up to Strong Buy on Solid Results
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:04AM CDT
On Aug 30, 2016, Zacks Investment Research upgraded CONE Midstream Partners LP (CNNX) to a Zacks Rank #1 (Strong Buy).
NBL: 34.25 (+0.40), CNX: 18.37 (+0.18), CNNX: 18.92 (+0.47), EEP: 24.00 (+0.62)

Noble Energy to Present at Upcoming Energy Conference
GlobeNewswire - Fri Aug 26, 7:00AM CDT
Noble Energy, Inc. (NYSE: NBL) announced today that David L. Stover, the Company's Chairman, President and CEO, will present at the Barclays' 2016 CEO Energy-Power Conference on Wednesday, September 7, 2016 at 9:45 a.m. Eastern Time.
NBL: 34.25 (+0.40)

Noble Energy Set to Possibly Rebound After Yesterday's Selloff of 1.83%
Comtex SmarTrend(R) - Mon Aug 22, 2:17PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $35.31 to a high of $35.83. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $35.44 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NBL: 34.25 (+0.40)

SmarTrend Watching for Potential Rebound in Shares of Noble Energy After 1.83% Loss
Comtex SmarTrend(R) - Mon Aug 22, 2:15PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $35.31 to a high of $35.83. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $35.44 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NBL: 34.25 (+0.40)

SmarTrend Watching for Potential Pullback in Shares of Noble Energy After 1.30% Gain
Comtex SmarTrend(R) - Tue Aug 16, 2:27PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $34.72 to a high of $35.85. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $35.53 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NBL: 34.25 (+0.40)

After Yesterday's Rally of 2.42% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 09, 1:04PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $32.91 to a high of $34.36. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $34.24 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NBL: 34.25 (+0.40)

Noble Energy Set to Possibly Pullback After Yesterday's Rally of 2.42%
Comtex SmarTrend(R) - Tue Aug 09, 1:02PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $32.91 to a high of $34.36. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $34.24 on volume of 3.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NBL: 34.25 (+0.40)

WPX Energy (WPX) Reports Wider-than-Expected Loss in Q2
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 11:11AM CDT
WPX Energy's (WPX) loss of 28 cents in the second quarter of 2016 was wider than expected.
NBL: 34.25 (+0.40), DVN: 44.27 (+0.57), WPX: 12.91 (+0.64), APC: 56.49 (+2.95)

CONE Midstream Reports Second Quarter Results and Increases Guidance
PR Newswire - Thu Aug 04, 5:45AM CDT
CONE Midstream Partners LP (NYSE: CNNX) ("CONE Midstream" or the "Partnership" today reported financial and operational results for the three months ended June 30, 2016.(1) The Partnership also increased guidance for full year 2016 financial results.
NBL: 34.25 (+0.40), CNX: 18.37 (+0.18), CNNX: 18.92 (+0.47)

After Yesterday's Decline of 2.76%, Noble Energy Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 03, 12:36PM CDT
Noble Energy (NYSE:NBL) traded in a range yesterday that spanned from a low of $33.20 to a high of $34.65. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $33.88 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
NBL: 34.25 (+0.40)

Noble (NBL) Q2 Loss Narrower than Expected; '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:18AM CDT
Noble Energy, Inc. (NBL) reported a loss of 24 cents per share for the second quarter, which was narrower than the Zacks Consensus Estimate of a loss of 31 cents.
NBL: 34.25 (+0.40), DVN: 44.27 (+0.57), MUR: 26.80 (+0.41), APC: 56.49 (+2.95)

Post Earnings Coverage as Atwood Tops Market Expectations
ACCESSWIRE - Wed Aug 03, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 3, 2016 / Active Wall St. announces its post-earnings coverage on Atwood Oceanics Inc. (NYSE: ATW). The company announced its third quarter fiscal 2016 results after market close on August 01, 2016. The offshore drilling company reported earnings above Wall Street's expectations. Atwood Oceanics also announced the purchase of $145.8 million of its senior notes on an average discount of 34.8%. Register with us now for your free membership at: http://www.activewallst.com/register/.
NBL: 34.25 (+0.40), KOS: 6.15 (+0.08), ATW: 7.97 (+0.33)

Noble (NBL) Q2 Loss Narrower than Expected, Revenues Lag
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:31AM CDT
Noble Energy's loss per share of 24 cents in second quarter was narrower than the Zacks Consensus Estimate loss of 30 cents.
NBL: 34.25 (+0.40)

Noble Energy Announces Strong Second Quarter Results, Raises Full-Year 2016 Volumes to Average 415 MBoe/d, While Maintaining Full-Year Capital Under $1.5 Billion
GlobeNewswire - Wed Aug 03, 6:04AM CDT
-- Achieved record quarterly sales volumes of 427 MBoe/d, an increase of 43 percent over the second quarter of 2015, or an 18 percent increase pro-forma. Also set records for quarterly volumes in the U.S. onshore assets and for a second quarter period in Israel.
NBL: 34.25 (+0.40)

Noble Energy (NBL): Stock to Beat Estimates in Q2 Earnings
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:46AM CDT
In the second quarter, oil prices rebounded from two-year lows, which will likely aid Noble Energy's (NBL) bottom line
NBL: 34.25 (+0.40), DVN: 44.27 (+0.57), NOG: 3.37 (+0.11), CHK: 6.60 (+0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading